Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis

• Takeo Nakanishi,

  Affiliation Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

  ⨯
• Yoshitaka Hasegawa ,

  Contributed equally to this work with: Yoshitaka Hasegawa, Reo Mimura

  Current address: Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Co., Ltd, Saitama, Japan

  Affiliation Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

  ⨯
• Reo Mimura ,

  Contributed equally to this work with: Yoshitaka Hasegawa, Reo Mimura

  Affiliation Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

  ⨯
• Tomohiko Wakayama,

  Affiliation Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

  ⨯
• Yuka Uetoko,

  Affiliation Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

  ⨯
• Hisakazu Komori,

  Affiliation Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

  ⨯
• Shin-ichi Akanuma,

  Affiliation Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

  ⨯
• Ken-ichi Hosoya,

  Affiliation Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

  ⨯
• Ikumi Tamai

  * E-mail: tamai@p.kanazawa-u.ac.jp

  Affiliation Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

  ⨯